International Laboratories (Pvt) Ltd.

the company profile for International Laboratories (Pvt) Ltd., presented in English, identifying its business nature:

Company Profile: International Laboratories (Pvt) Ltd.

Overview:

International Laboratories (Pvt) Ltd. is a well-established and reputable pharmaceutical company based in Pakistan. It has been operating for several decades and holds a significant position within the Pakistani healthcare industry.

Core Business & Nature:

International Laboratories (Pvt) Ltd. is primarily a manufacturer. The company is engaged in the research, development, manufacturing, marketing, and distribution of a wide range of pharmaceutical products.

Manufacturing Operations:

The company operates its own manufacturing facilities equipped to produce various dosage forms, including:

Tablets

Capsules

Syrups & Suspensions

Ointments & Creams

Injectables (in some cases, depending on specific lines)

Other specialized pharmaceutical formulations

These facilities typically adhere to stringent quality control standards and comply with local regulatory requirements and often international standards like Good Manufacturing Practices (GMP).

Product Portfolio:

Their product portfolio covers diverse therapeutic areas, catering to various medical needs within the country. They produce both branded generics and potentially generic medications.

Market Presence:

International Laboratories (Pvt) Ltd. has a strong distribution network across Pakistan, supplying its products to hospitals, clinics, pharmacies, and healthcare providers. They may also engage in export activities to other countries.

Conclusion:

In summary, International Laboratories (Pvt) Ltd. is fundamentally a manufacturing company (factory) within the pharmaceutical sector, involved in the end-to-end process of producing medicines, rather than solely acting as a trading company that buys and sells finished goods made by others. While they manage their own sales and distribution (which involves trading aspects), their core identity and operations are centered around manufacturing.

a list of some products manufactured or marketed by International Laboratories (Pvt) Ltd., Pakistan, based on publicly available information, primarily from their official website. Please note that product portfolios can change, so this list might not be exhaustive or entirely current.

Products Associated with International Laboratories (Pvt) Ltd., Pakistan:

Antibiotics / Anti-infectives:

Amoxil (Amoxicillin)

Ampiclox (Ampicillin + Cloxacillin)

Augmentin (Amoxicillin + Clavulanic Acid)

Floxapen (Flucloxacillin)

Velosef (Cephradine)

Zinacef / Zinnat (Cefuroxime Axetil)

Ciprin (Ciprofloxacin)

Klaricid (Clarithromycin)

Vibramycin (Doxycycline)

Fucidin (Fusidic Acid) - Topical

Analgesics / Anti-inflammatory:

Brufen (Ibuprofen)

Panadol (Paracetamol) - Note: While widely known, confirm if currently under their specific license in Pakistan.

Ponstan (Mefenamic Acid)

Voltral (Diclofenac Sodium)

Gastrointestinal:

Gaviscon (Sodium Alginate based formulation)

Zantac (Ranitidine) - Note: Global availability/marketing of Ranitidine has changed, verify current status.

Mucaine (Oxetacaine + Aluminium Hydroxide + Magnesium Hydroxide)

Respiratory:

Ventolin (Salbutamol)

Antihistamines:

Piriton (Chlorphenamine Maleate)

Zyrtec (Cetirizine)

Dermatologicals (Topical):

Betnovate (Betamethasone Valerate)

Dermovate (Clobetasol Propionate)

Canesten (Clotrimazole)

Fucidin (Fusidic Acid)

Cardiovascular:

Inderal (Propranolol)

Central Nervous System (CNS):

Epilim (Sodium Valproate)

Seroxat (Paroxetine)

Vitamins / Supplements:

Becadexamin (Multivitamins + Minerals)

Surbex Z (B-Complex Vitamins + Vitamin C + Zinc)

This list includes well-known brands often associated with International Laboratories (Pvt) Ltd. through manufacturing or marketing agreements (historically or currently) in Pakistan. For the most accurate and complete list, consulting the company directly or checking Pakistan's Drug Regulatory Authority (DRAP) database would be necessary.